A cross-sectional nationwide survey of adults in the US in 2021. The rate of psychedelic use, comorbid conditions, mental and physical health, and factors predictive of psychedelic use were assessed.

Population Health Data Survey – Patient Reported Data

Request a sample

Details

User consent

Yes

Records volume

7138

Data History

2021

Data Source

✔Other | Patient Reported Data

Prevalent Dx (diagnoses)

Depression; Anxiety; PTSD; Addiction; Chronic pain; Allergies; Migraines; Insomnia; Hypertension; Sleep apnea; Gastrointestinal; GERD

Prevalent Rx/Tx (Drug/treatment protocols)

Psychedelic mushrooms

Combined (Tx) therapy

none

Additional Data Features?

Morlock​,​ Robert (2021)​,​ Data from: Psychedelic mushrooms in the USA: knowledge​,​ patterns of use​,​ and association with health outcomes​,​ Dryad​,​ Dataset​,​ https://doi.org/10.5061/dryad.bzkh189b6

Source

88la